Stanford’s newest Nobel laureate, Carolyn Bertozzi, details how fundamental science enabled her to invent bioorthogonal chemistry, a tool now used in therapies for cancer. She shares the $10 million Swedish kronor (about $1 million USD) prize equally with Morten Meldal, professor at University of Copenhagen; and K. Barry Sharpless, (who received his doctorate from Stanford in 1968), professor at Scripps Research, “for the development of click chemistry and bioorthogonal chemistry.”

Featured in this video:
Carolyn Bertozzi, the Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences, Baker Director of Sarafan ChEM-H, and Professor of Chemistry.
Christopher O. Barnes, Assistant Professor of Biology and Sarafan ChEM-H scholar

свернуть